首页> 外国专利> ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER

ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER

机译:M(H)DM2 / 4的抗体及其在诊断和治疗癌症中的用途

摘要

The present invention relates to certain anti-M(H)DM2/4 antibodies orantigen- binding fragments thereof, pharmaceutical compositionscomprising anti-M(H)DM2/4 antibodies or antigen-binding fragmentsthereof, antibody-drug conjugates comprising anti-M(H)DM2/4 antibodies orantigen-binding fragments thereof bound to a cytotoxic drug, and the use ofsuchantibodies, fragments, compositions and conjugates for treating cancer and/or for preventing metastases. In particular, described herein are certainantibodies or antigen-binding fragments thereof that specifically bind toextracellularly accessible epitopes of M(H)DM2/4 and inhibit tumor growth invivo,pharmaceutical compositions comprising such antibodies or fragments,antibody-drug conjugates comprising such antibodies or fragments, and the useof such antibodies, fragments, compositions and conjugates for treatingcancer or for preventing metastasis.
机译:本发明涉及某些抗M(H​​)DM2 / 4抗体或其抗原结合片段,药物组合物包含抗M(H)DM2 / 4抗体或抗原结合片段其,包含抗M(H)DM2 / 4抗体的抗体-药物偶联物或其抗原结合片段与细胞毒性药物结合,以及其用途这样用于治疗癌症和/的抗体,片段,组合物和缀合物或用于预防转移。特别地,本文描述是确定的与之特异性结合的抗体或其抗原结合片段M(H)DM2 / 4的细胞外可访问表位并抑制肿瘤的生长体内包含此类抗体或片段的药物组合物,包含此类抗体或片段的抗体-药物缀合物及其用途此类抗体,片段,组合物和结合物的治疗癌症或预防转移。

著录项

  • 公开/公告号CA3071105A1

    专利类型

  • 公开/公告日2019-01-31

    原文格式PDF

  • 申请/专利权人 NOMOCAN PHARMACEUTICALS LLC;

    申请/专利号CA20183071105

  • 发明设计人 SARAFRAZ-YAZDI EHSUN;EVANS BRAD R.;

    申请日2018-07-26

  • 分类号A61K39;C07K16/28;C07K16/30;

  • 国家 CA

  • 入库时间 2022-08-21 11:58:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号